Molecular Testing in Metastatic Gastric/GEJ Cancer
3 vistas
• 06/30/23
0
0
Empotrar
administrator
Suscriptores
David Ilson, MD, PhD, reflects on the role of molecular testing in the treatment of metastatic gastric/gastroesophageal junction cancer and its impact on prognosis and clinical decision making.
Mostrar más
Comentarios de Facebook
SORT BY-
Top Comentarios
-
Últimos comentarios